DOP75 Effectiveness and Safety of tofacitinib versus vedolizumab in Patients with Ulcerative Colitis; A Nationwide, ICC Registry studyTessa Straatmijer, Marjolijn Duijvestein, Andrica de Vries et al.|Journal of Crohn s and Colitis|2022Cited by 0